{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,12]],"date-time":"2026-07-12T02:27:04Z","timestamp":1783823224574,"version":"3.55.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,1,5]],"date-time":"2021-01-05T00:00:00Z","timestamp":1609804800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,5]],"date-time":"2021-01-05T00:00:00Z","timestamp":1609804800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1007\/s12020-020-02571-3","type":"journal-article","created":{"date-parts":[[2021,1,5]],"date-time":"2021-01-05T15:06:28Z","timestamp":1609859188000},"page":"582-585","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Cardiovascular outcome in patients with adrenal insufficiency\u2014a therapeutic dilemma"],"prefix":"10.1007","volume":"72","author":[{"given":"Amir-Hossein","family":"Rahvar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Riesel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Graf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4886-0769","authenticated-orcid":false,"given":"Birgit","family":"Harbeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,5]]},"reference":[{"key":"2571_CR1","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1210\/jc.2015-1710","volume":"101","author":"SR Bornstein","year":"2016","unstructured":"S.R. Bornstein, B. Allolio, W. Arlt, A. Barthel, A. Don-Wauchope, G.D. Hammer, E.S. Husebye, D.P. Merke, M.H. Murad, C.A. Stratakis, D. Torpy, Diagnosis and treatment of primary adrenal insufficiency: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 101, 364\u2013389 (2016)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2571_CR2","doi-asserted-by":"publisher","first-page":"3691913","DOI":"10.1155\/2017\/3691913","volume":"2017","author":"AH Rahvar","year":"2017","unstructured":"A. H. Rahvar, C.S. Haas, S. Danneberg, B. Harbeck, Increased cardiovascular risk in patients with adrenal insufficiency: a short review. Biomed. Res. Int. 2017, 3691913 (2017)","journal-title":"Biomed. Res. Int."},{"key":"2571_CR3","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.tem.2005.07.004","volume":"16","author":"EM Erfurth","year":"2005","unstructured":"E.M. Erfurth, L. Hagmar, Cerebrovascular disease in patients with pituitary tumors. Trends Endocrinol. Metab. 16, 334\u2013342 (2005)","journal-title":"Trends Endocrinol. Metab."},{"key":"2571_CR4","doi-asserted-by":"publisher","first-page":"3888","DOI":"10.1210\/jc.2016-2118","volume":"101","author":"M Fleseriu","year":"2016","unstructured":"M. Fleseriu, I.A. Hashim, N. Karavitaki, S. Melmed, M.H. Murad, R. Salvatori, M.H. Samuels, Hormonal replacement in hypopituitarism in adults: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 101, 3888\u20133921 (2016)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2571_CR5","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s11102-008-0126-2","volume":"11","author":"K Danilowicz","year":"2008","unstructured":"K. Danilowicz, O.D. Bruno, M. Manavela, R.M. Gomez, A. Barkan, Correction of cortisol overreplacement ameliorates morbidities in patients with hypopituitarism: a pilot study. Pituitary 11, 279\u2013285 (2008)","journal-title":"Pituitary"},{"key":"2571_CR6","doi-asserted-by":"publisher","first-page":"3954","DOI":"10.1210\/jc.2006-0524","volume":"91","author":"H Filipsson","year":"2006","unstructured":"H. Filipsson, J.P. Monson, M. Koltowska-Haggstrom, A. Mattsson, G. Johannsson, The impact of glucocorticoid replacement regimens on metabolic outcome and comorbidity in hypopituitary patients. J. Clin. Endocrinol. Metab. 91, 3954\u20133961 (2006)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2571_CR7","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1530\/EJE-08-0874","volume":"160","author":"M Debono","year":"2009","unstructured":"M. Debono, R.J. Ross, J. Newell-Price, Inadequacies of glucocorticoid replacement and improvements by physiological circadian therapy. Eur. J. Endocrinol. 160, 719\u2013729 (2009)","journal-title":"Eur. J. Endocrinol."},{"key":"2571_CR8","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.1210\/jc.2013-4305","volume":"99","author":"CJ Petersons","year":"2014","unstructured":"C.J. Petersons, B.L. Mangelsdorf, C.H. Thompson, M.G. Burt, Acute effect of increasing glucocorticoid replacement dose on cardiovascular risk and insulin sensitivity in patients with adrenocorticotrophin deficiency. J. Clin. Endocrinol. Metab. 99, 2269\u20132276 (2014)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2571_CR9","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1111\/j.1365-2265.2012.04352.x","volume":"77","author":"B Ekman","year":"2012","unstructured":"B. Ekman, M. Bachrach-Lindstr\u00f6m, T. Lindstr\u00f6m, J. Wahlberg, J. Blomgren, H.J. Arnqvist, A randomized, double-blind, crossover study comparing two-and four-dose hydrocortisone regimen with regard to quality of life, cortisol and ACTH profiles in patients with primary adrenal insufficiency. Clin. Endocrinol. (Oxf.) 77, 18\u201325 (2012)","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"2571_CR10","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1210\/jc.2011-1926","volume":"97","author":"G Johannsson","year":"2012","unstructured":"G. Johannsson, A.G. Nilsson, R. Bergthorsdottir, P. Burman, P. Dahlqvist, B. Ekman, B.E. Engstr\u00f6m, T. Olsson, O. Ragnarsson, M. Ryberg, J. Wahlberg, B.M. Biller, J.P. Monson, P.M. Stewart, H. Lennernas, S. Skrtic, Improved cortisol exposure-time profile and outcome in patients with adrenal insufficiency: a prospective randomized trial of a novel hydrocortisone dual-release formulation. J. Clin. Endocrinol. Metab. 97, 473\u2013481 (2012)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2571_CR11","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1007\/s12020-020-02187-7","volume":"67","author":"LM Mongioi","year":"2020","unstructured":"L.M. Mongioi, R.A. Condorelli, F. Barbagallo, S. La Vignera, A.E. Calogero, Dual-release hydrocortisone for treatment of adrenal insufficiency: a systematic review. Endocrine 67, 507\u2013515 (2020)","journal-title":"Endocrine"},{"key":"2571_CR12","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1530\/EJE-14-1114","volume":"172","author":"M Quinkler","year":"2015","unstructured":"M. Quinkler, R. Miodini Nilsen, K. Zopf, M. Ventz, M. Oksnes, Modified-release hydrocortisone decreases BMI and HvA1c in patients with primary and secondary adrenal insufficiency. Eur. J. Endocrinol. 172, 619\u2013626 (2015)","journal-title":"Eur. J. Endocrinol."},{"key":"2571_CR13","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1007\/s12020-015-0681-z","volume":"51","author":"R Giordano","year":"2016","unstructured":"R. Giordano, F. Guaraldi, E. Marinazzo, F. Fumarola, A. Rampino, R. Berardelli, I. Karamouzis, M. Lucchiari, T. Manetta, G. Mengozzi, E. Arvat, E. Ghigo, Improvement of anthropometric and metabolic parameters, and quality of life following treatment with dual-release hydrocortisone in patients with Addisons disease. Endocrine 51, 360\u2013368 (2016)","journal-title":"Endocrine"},{"key":"2571_CR14","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1530\/EC-18-0257","volume":"7","author":"F Ceccato","year":"2018","unstructured":"F. Ceccato, E. Selmin, E. Sabbadin, M. Dalla Costa, G. Antonelli, M. Plebani, M. Barbot, C. Betterle, M. Boscaro, C. Scaroni, Improved salivary cortisol rhythm with dual-release hydrocortisone. Endocr. Connect. 7, 965\u2013974 (2018)","journal-title":"Endocr. Connect."},{"key":"2571_CR15","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1530\/EC-19-0176","volume":"8","author":"V Guarnotta","year":"2019","unstructured":"V. Guarnotta, C. Di Stefano, A. Santoro, A. Ciresi, A. Coppola, C. Giordano, Dual-release hydrocortisone vs conventional glucocorticoids in adrenal insufficiency. Endocr. Connect. 8, 853\u2013862 (2019)","journal-title":"Endocr. Connect."},{"key":"2571_CR16","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1530\/EC-17-0368","volume":"7","author":"LM Mongioi","year":"2018","unstructured":"L.M. Mongioi, R.A. Condorelli, S. La Vignera, A.E. Calogero, Dual-release hydrocortisone treatment: gylcometabolic profile and health-related quality of life. Endocr. Connect. 7, 211\u2013219 (2018)","journal-title":"Endocr. Connect."},{"key":"2571_CR17","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/S2213-8587(17)30398-4","volume":"6","author":"AM Isidori","year":"2018","unstructured":"A.M. Isidori, M.A. Venneri, C. Graziadio, C. Simeoli, D. Fiore, V. Hasenmajer, E. Sbardella, D. Gianfrilli, C. Pozza, P. Pasqualetti, S. Morrone, A. Santoni, F. Naro, A. Colao, R. Pivonello, A. Lenzi, Effect of once-daily, modified-release hydrocortisone versus standard glucocorticoid therapy on metabolism and innate immunity in patients with adrenal insufficiency (DREAM): a single-blind, randomized controlled trial. Lancet Diabetes Endocrinol. 6, 173\u2013185 (2018)","journal-title":"Lancet Diabetes Endocrinol."},{"key":"2571_CR18","doi-asserted-by":"publisher","first-page":"2303","DOI":"10.1210\/jcem.81.6.8964868","volume":"81","author":"DA Papanicolaou","year":"1996","unstructured":"D.A. Papanicolaou, C. Tsigos, E.H. Oldfield, G.P. Chrousos, Acute glucocorticoid deficiency is associated with plasma elevations of interleukin-6: does the latter participate in the symptomatology of the steroid withdrawal syndrome and adrenal insufficiency? J. Clin. Endocrinol. Metab. 81, 2303\u20132306 (1996)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2571_CR19","doi-asserted-by":"crossref","unstructured":"IL-6R Genetics Consortium Emerging Risk Factors Collaboration et al. Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies. Lancet 379, 1205\u20131213 (2012)","DOI":"10.1016\/S0140-6736(11)61931-4"},{"key":"2571_CR20","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1007\/s12020-019-01956-3","volume":"64","author":"AH Rahvar","year":"2019","unstructured":"A.H. Rahvar, M. Riesel, T. Graf, B. Harbeck, Adrenal Insufficiency treated with conventional hydrocortisone leads to elevated levels of interleukin-6: a pilot study. Endocrine 64, 727\u2013729 (2019)","journal-title":"Endocrine"},{"key":"2571_CR21","doi-asserted-by":"crossref","unstructured":"Interleukin-6 Receptor Mendelian Randomisation Analysis (IL6RMR) Consortium et al. The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomization analysis. Lancet 379, 1214\u20131224 (2012)","DOI":"10.1016\/S0140-6736(12)60110-X"},{"key":"2571_CR22","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1161\/01.CIR.101.15.1767","volume":"101","author":"PM Ridker","year":"2000","unstructured":"P.M. Ridker, N. Rifai, M.J. Stampfer, C.H. Hennekens, Plasma concentration of interleukin- 6 and the risk of future myocardial infarction among apparently healthy men. Circulation 101, 1767\u20131772 (2000)","journal-title":"Circulation"},{"key":"2571_CR23","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1161\/JAHA.116.005038","volume":"6","author":"BC Bacchiega","year":"2017","unstructured":"B.C. Bacchiega, A.B. Bacchiega, M.J. Usnayo, R. Bedirian, G. Singh, G.D. Pinheiro, Interleukin 6 inhibition and coronary artery disease in a high-risk population: a prospective community-based clinical study. J. Am. Heart Assoc. 6, 3 (2017)","journal-title":"J. Am. Heart Assoc."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-020-02571-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-020-02571-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-020-02571-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,17]],"date-time":"2021-05-17T10:19:46Z","timestamp":1621246786000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-020-02571-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,5]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["2571"],"URL":"https:\/\/doi.org\/10.1007\/s12020-020-02571-3","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,5]]},"assertion":[{"value":"6 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of University Luebeck, Germany (No. 171\/07).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}